Fundamental Neurochemistry Review: Microglial immunometabolism in traumatic brain injury

Traumatic brain injury (TBI) is a devastating neurological disorder caused by a physical impact to the brain that promotes diffuse damage and chronic neurodegeneration. Key mechanisms believed to support secondary brain injury include mitochondrial dysfunction and chronic neuroinflammation. Microgli...

Full description

Saved in:
Bibliographic Details
Published inJournal of neurochemistry Vol. 167; no. 2; pp. 129 - 153
Main Authors Strogulski, Nathan R., Portela, Luis V., Polster, Brian M., Loane, David J.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.10.2023
Subjects
Online AccessGet full text
ISSN0022-3042
1471-4159
1471-4159
DOI10.1111/jnc.15959

Cover

More Information
Summary:Traumatic brain injury (TBI) is a devastating neurological disorder caused by a physical impact to the brain that promotes diffuse damage and chronic neurodegeneration. Key mechanisms believed to support secondary brain injury include mitochondrial dysfunction and chronic neuroinflammation. Microglia and brain‐infiltrating macrophages are responsible for neuroinflammatory cytokine and reactive oxygen species (ROS) production after TBI. Their production is associated with loss of homeostatic microglial functions such as immunosurveillance, phagocytosis, and immune resolution. Beyond providing energy support, mitochondrial metabolic pathways reprogram the pro‐ and anti‐inflammatory machinery in immune cells, providing a critical immunometabolic axis capable of regulating immunologic response to noxious stimuli. In the brain, the capacity to adapt to different environmental stimuli derives, in part, from microglia's ability to recognize and respond to changes in extracellular and intracellular metabolite levels. This capacity is met by an equally plastic metabolism, capable of altering immune function. Microglial pro‐inflammatory activation is associated with decreased mitochondrial respiration, whereas anti‐inflammatory microglial polarization is supported by increased oxidative metabolism. These metabolic adaptations contribute to neuroimmune responses, placing mitochondria as a central regulator of post‐traumatic neuroinflammation. Although it is established that profound neurometabolic changes occur following TBI, key questions related to metabolic shifts in microglia remain unresolved. These include (a) the nature of microglial mitochondrial dysfunction after TBI, (b) the hierarchical positions of different metabolic pathways such as glycolysis, pentose phosphate pathway, glutaminolysis, and lipid oxidation during secondary injury and recovery, and (c) how immunometabolism alters microglial phenotypes, culminating in chronic non‐resolving neuroinflammation. In this basic neurochemistry review article, we describe the contributions of immunometabolism to TBI, detail primary evidence of mitochondrial dysfunction and metabolic impairments in microglia and macrophages, discuss how major metabolic pathways contribute to post‐traumatic neuroinflammation, and set out future directions toward advancing immunometabolic phenotyping in TBI. image
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
No
Brian M. Polster, PhD Department of Anesthesiology and Center for Shock, Trauma and Anesthesiology Research, University of Maryland School of Medicine, 685 W. Baltimore St., MSTF 5-34, Baltimore, MD 21201, USA, bpolster@som.umaryland.edu
"All experiments were conducted in compliance with the ARRIVE guidelines." unless it is a Review or Editorial
NRS: Conceptualization, Writing - Original Draft, Writing - Review & Editing, Funding acquisition. LVP: Writing - Review & Editing, Funding acquisition. BMP: Writing - Review & Editing, Funding acquisition. DJL: Conceptualization, Writing - Original Draft, Writing - Review & Editing, Funding acquisition.
if it is a Review or Editorial, skip complete sentence
Author contribution statement
Author contributions--
NA
if No, include a statement in the "Conflict of interest disclosure" section: "ARRIVE guidelines were not followed for the following reason
ARRIVE guidelines have been followed
(edit phrasing to form a complete sentence as necessary).
Luis Valmor Portela, PhD, Laboratory of Neurotrauma and Biomarkers, Departamento de Bioquímica, ICBS, Universidade Federal do Rio Grande do Sul, UFRGS, Rua Ramiro Barcelos 2600, anexo, Bairro Santana, Porto Alegre, RS, Brasil, roskaportela@gmail.com
if Yes, insert in the "Conflict of interest disclosure" section
ISSN:0022-3042
1471-4159
1471-4159
DOI:10.1111/jnc.15959